CymaBay Therapeutics, Inc.

Report date
12/31/2023
Quarter
2023 Q4
Filed
2/13/2024
Shares
132,809
Value ($000)
3,137
Weight
0.0%
2020 Q2 - 2023 Q4 (8 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).